View More Recent Stories

Feb 9, 2025 09:10AM Faruqi & Faruqi Reminds Neumora Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7. 2025 - NMRA
Jan 6, 2025 04:38AM Neumora Therapeutics (NMRA) PT Lowered to $7 at BofA Securities
Jan 3, 2025 06:36AM H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)
Jan 3, 2025 06:35AM Mizuho Reiterates Outperform Rating on Neumora Therapeutics (NMRA)
Jan 2, 2025 11:06AM RBC Capital Downgrades Neumora Therapeutics (NMRA) to Sector Perform
Jan 2, 2025 07:01AM Neumora Therapeutics (NMRA) Reports Data from KOASTAL-1 Study of Navacaprant
Jan 2, 2025 05:55AM Neumora Therapeutics (NMRA) call put ratio 1 call to 1 put on 17K contracts
Dec 26, 2024 05:36AM Neumora Therapeutics (NMRA) call put ratio 1 call to 1.4 puts on 13K contracts
Dec 24, 2024 05:31AM Neumora Therapeutics (NMRA) call put ratio 1 call to 2.8 puts on 12K contracts
Dec 16, 2024 06:53AM H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)
Dec 6, 2024 03:38PM RBC Capital Reiterates Outperform Rating on Neumora Therapeutics (NMRA)
Nov 22, 2024 10:20AM Increasing unusual option volume: NMRA MSTZ ESTC ROST OMER IJH CYH QBTS HYLN
Nov 12, 2024 07:08AM Neumora Therapeutics, Inc. (NMRA) Tops Q3 EPS by 20c
Nov 5, 2024 03:15AM JPMorgan Downgrades Neumora Therapeutics (NMRA) to Neutral
Oct 1, 2024 06:08AM H.C. Wainwright Starts Neumora Therapeutics (NMRA) at Buy
Sep 19, 2024 06:54AM Mizuho Reiterates Outperform Rating on Neumora Therapeutics (NMRA)
Sep 12, 2024 07:53AM Mizuho Reiterates Outperform Rating on Neumora Therapeutics (NMRA)
Sep 9, 2024 06:37AM Mizuho Reiterates Outperform Rating on Neumora Therapeutics (NMRA)
Sep 6, 2024 06:22AM Mizuho Reiterates Outperform Rating on Neumora Therapeutics (NMRA)
Jul 8, 2024 06:23AM Mizuho Starts Neumora Therapeutics (NMRA) at Outperform
Jun 17, 2024 06:23AM RBC Capital Reiterates Outperform Rating on Neumora Therapeutics (NMRA)
View More Recent Stories